Sanara MedTech (SMTI) Operating Leases (2019 - 2026)

Sanara MedTech has reported Operating Leases for 8 years, with the latest figure at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 34.39% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 34.39% YoY), and the FY2025 full-year result was $1.9 million, up 51.06% from the prior year.
• Operating Leases for Q1 2026 stood at $1.8 million, down from $1.9 million in the prior quarter.
• The five-year high for Operating Leases was $2.2 million in Q3 2023, with the low at $151378.0 in Q2 2022.
• Historically, Operating Leases has averaged $1.4 million across 5 years, with a median of $1.8 million in 2026.
• Annual changes were most pronounced in 2022 — Operating Leases sank 63.88% — and 2023, when it surged 1075.48%.
• Sanara MedTech's Operating Leases stood at $505291.0 in 2022, then soared by 243.85% to $1.7 million in 2023, then declined by 28.8% to $1.2 million in 2024, then surged by 51.06% to $1.9 million in 2025, then retreated by 5.24% to $1.8 million in 2026.
• The last three Operating Leases figures came in at $1.8 million (Q1 2026), $1.9 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.